Bud APAC announced the unaudited performance for the nine months ended September 30, 2024 on October 31, 2024. The report shows a total sales volume decrease of 8.1% during the period, a revenue decrease of 6.1%, and a growth of 2.2% in revenue per hundred liters. CEO Yang Ke stated that the weak performance in the China market dragged down the overall results, but the strong growth in the South Korea and India markets partly offset the decline. The normalized profit attributable to Bud APAC shareholders decreased from $879 million for the first nine months of 2023 to $777 million for the first nine months of 2024. The company emphasizes that unaudited financial data should not be the sole basis for investment decisions. The board of directors reminds shareholders and potential investors to act cautiously and not overly rely on unaudited performance.

Bud APAC announced the unaudited performance for the nine months ended September 30, 2024 on October 31, 2024. The report shows a total sales volume decrease of 8.1% during the period, a revenue decrease of 6.1%, and a growth of 2.2% in revenue per hundred liters. CEO Yang Ke stated that the weak performance in the China market dragged down the overall results, but the strong growth in the South Korea and India markets partly offset the decline. The normalized profit attributable to Bud APAC shareholders decreased from $879 million for the first nine months of 2023 to $777 million for the first nine months of 2024. The company emphasizes that unaudited financial data should not be the sole basis for investment decisions. The board of directors reminds shareholders and potential investors to act cautiously and not overly rely on unaudited performance.